VITASPRING BIOMEDICAL CO., LTD. SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense of $7.68 thousand for the 6-month period ending 2019-07-31, per its 10-Q filed 2019-08-27.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense · last filed 2019-08-27
- 2019-07-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 6 month $7.68K.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 6 month |
|---|---|
| 2019-07-31 | $7.68K 10-Q · filed 2019-08-27 |